House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Infectious diseases

Cough (acute): antimicrobial prescribing

NICE · 2019 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE guideline NG120 covers antimicrobial prescribing for acute cough in adults, young people and children. It focuses on acute cough linked to an upper respiratory tract infection or acute bronchitis. It covers expected illness course, referral, symptomatic and self-care treatments, and when to use no, back-up or immediate antibiotics. It also gives safety-netting advice, reassessment triggers and antibiotic choice with age-specific dosing. Acute cough with suspected or confirmed COVID-19, suspected pneumonia and fever in under-5s are directed to other NICE guidance. Recommendations stress that most acute cough is viral and self-limiting, and that antibiotics give little benefit. Antibiotics are not offered for cough with an upper respiratory tract infection, and not routinely offered for acute bronchitis, in people who are not systemically very unwell or at higher risk of complications. The committee notes that antibiotics may be an option for some people on an individual patient basis. Immediate antibiotics are offered to people who are systemically very unwell. Immediate or back-up antibiotics are considered for people at higher risk of complications.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Assessment, scope and referral

  • Acute cough usually resolves without antibiotics within 3 to 4 weeks. It is most often caused by a viral upper respiratory tract infection. It can also result from acute bronchitis, which is usually viral but can be bacterial, or from other infective or non-infective causes. [1]
  • For children under 5 who have both acute cough and fever, use the separate NICE fever in under 5s guideline. For acute cough in people with suspected or confirmed COVID-19, use the NICE rapid guideline on managing COVID-19. [1]
  • For adults, children and young people with acute cough and suspected pneumonia, use the NICE COVID-19 rapid guideline if the pneumonia is secondary to COVID-19. For pneumonia not secondary to COVID-19, use the community-acquired or hospital-acquired pneumonia antimicrobial prescribing guidelines. [1]
  • Refer to hospital, or seek specialist advice on further investigation and management, when symptoms or signs suggest a more serious illness or condition such as sepsis, pulmonary embolism or lung cancer. [1]

General advice, symptomatic treatments and self-care

  • Give people general advice covering three points: - the expected course of acute cough (up to 3 or 4 weeks); - managing symptoms with self-care; - when to seek medical help, for example rapid or significant worsening, no improvement after 3 to 4 weeks, or becoming systemically very unwell. [1]
  • Do not offer oral or inhaled bronchodilators (such as salbutamol) or oral or inhaled corticosteroids for cough due to an upper respiratory tract infection or acute bronchitis. The exception is people with underlying airways disease such as asthma. [1]
  • Do not offer mucolytics such as acetylcysteine or carbocisteine for cough due to an upper respiratory tract infection or acute bronchitis. [1]
  • Some people may wish to try self-care treatments that have limited evidence of some benefit for cough relief: - honey, for those over 1 year; - pelargonium, a herbal medicine, for those 12 and over; - over-the-counter guaifenesin expectorant medicines, for those 12 and over. Limited evidence suggests that antihistamines, decongestants and codeine-containing cough medicines do not help cough. [1]
  • People aged 12 and over may also wish to try over-the-counter cough suppressants other than codeine as self-care. These have limited evidence of some benefit. This option excludes people with a persistent cough (for example in asthma) or excessive secretions. [1]

Deciding whether to prescribe an antibiotic

  • For cough due to an upper respiratory tract infection, do not offer an antibiotic to people who are neither systemically very unwell nor at higher risk of complications. Explain why an antibiotic is not needed. [1]
  • For cough due to acute bronchitis, antibiotics should not routinely be offered to people who are neither systemically very unwell nor at higher risk of complications. In acute bronchitis, antibiotics do not improve overall clinical condition. They shorten cough by only about half a day on average, and they can cause adverse effects, especially diarrhoea and nausea. [1]
  • If no antibiotic is prescribed, explain why one is not needed. If an antibiotic is prescribed, including an immediate prescription, warn about possible adverse effects, particularly diarrhoea and nausea. [1]
  • Offer an immediate antibiotic prescription to people judged systemically very unwell, ideally at a face-to-face examination. Choose the antibiotic as described in the antibiotic choice recommendation. [1]
  • People with acute cough may be at higher risk of complications in either of these situations: - a pre-existing comorbidity such as significant heart, lung, renal, liver or neuromuscular disease, immunosuppression or cystic fibrosis; - young children who were born prematurely. [1]
  • Higher risk of complications may also apply to people older than 65 years with 2 or more of the criteria below, or older than 80 years with 1 or more of them. The criteria are: - hospitalisation in the previous year; - type 1 or type 2 diabetes; - history of congestive heart failure; - current oral corticosteroid use. [1]
  • For people identified as at higher risk of complications, ideally face to face, consider either an immediate antibiotic prescription (chosen as described in the antibiotic choice recommendation) or a back-up antibiotic prescription. [1]

Back-up prescriptions and reassessment

  • When giving a back-up prescription, explain that an antibiotic is not needed immediately. Advise using it if symptoms worsen rapidly or significantly at any time. [1]
  • Reassess if symptoms worsen rapidly or significantly. Take account of: - alternative diagnoses such as pneumonia; - symptoms or signs of a more serious illness or condition, such as cardiorespiratory failure or sepsis; - previous antibiotic use that may have led to resistant bacteria. [1]

Choice of antibiotic and dosing

  • The first-choice antibiotic for adults aged 18 years and over is doxycycline: 200 mg on the first day, then 100 mg once a day for 4 days (5-day course in total). [1]
  • Alternative first choices for adults aged 18 years and over include amoxicillin 500 mg three times a day for 5 days, and clarithromycin 250 mg to 500 mg twice a day for 5 days. [1]
  • Erythromycin is also an alternative first choice for adults aged 18 years and over. The dose is 250 mg to 500 mg four times a day, or 500 mg to 1,000 mg twice a day, for 5 days. [1]
  • Consider possible pregnancy in women of childbearing age. In pregnancy: - doxycycline should not be used; - amoxicillin is preferred; - erythromycin is the preferred macrolide when one is needed, for example with true penicillin allergy where treatment benefits outweigh harms. For appropriate use and dosing in specific populations, check the BNF (hepatic or renal impairment, pregnancy and breastfeeding) or the BNF for children (hepatic or renal impairment). [1]
  • For children and young people, first-choice amoxicillin is given three times a day for 5 days, by age band: - 125 mg for 1 month to 11 months; - 250 mg for 1 year to 4 years; - 500 mg for 5 years to 17 years. Age bands assume a child of average size. Prescribers should use them alongside other factors such as severity and the child's size relative to others of the same age. [1]
  • Alternative first choices for children and young people are clarithromycin, erythromycin, and doxycycline. Doxycycline is listed only for ages 12 years to 17 years. Each uses the age- or weight-banded regimens in Table 2. At 12 years to 17 years, clarithromycin is 250 mg to 500 mg twice a day for 5 days. [1]

Limitations and use

  • Acute cough in suspected or confirmed COVID-19, and suspected pneumonia, are managed under other NICE guidelines and are not covered here.
  • Children under 5 with acute cough and fever are directed to the separate NICE fever in under 5s guideline.
  • No recommendation was made for children with prolonged moist cough of more than 10 days.
  • Several herbal products, NSAIDs and oral salbutamol with dextromethorphan received no recommendation.
  • Most of the supporting evidence was rated low or very low quality.
  • Recommendation 1.1.11 has been removed from the guideline.
  • Dosing in hepatic or renal impairment, pregnancy and breastfeeding is deferred to the BNF and BNF for children.
  • Research recommendations and later non-clinical sections were not reviewed for this summary.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Cough (acute): antimicrobial prescribing

    Guideline recommendation text consulted

Original guideline

Publication details

Issuing organisation
NICE
First published
7 February 2019
Resource type
Clinical guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Assessment, scope and referral
  • General advice, symptomatic treatments and self-care
  • Deciding whether to prescribe an antibiotic
  • Back-up prescriptions and reassessment
  • Choice of antibiotic and dosing
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House